Dorina B. Cultrera
Catania, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part B.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 23, 2024
IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 17, 2022
Efficacy of Replacement and Anti-Platelet Therapies in a Patient with Severe Haemophilia A Undergoing Percutaneous Coronary Stent Implantation.
Journal: European journal of case reports in internal medicine
Published: April 06, 2022
Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panel.
Journal: European journal of haematology
Published: January 05, 2022
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 01, 2021
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET.
Journal: Blood transfusion = Trasfusione del sangue
Published: August 07, 2019
Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A.
Journal: Patient preference and adherence
Published: February 19, 2019
Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.
Journal: Blood transfusion = Trasfusione del sangue
Published: December 12, 2016
Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: January 08, 2015
Cost-Consequences Analysis of the Long-Term Prophylaxis In A Type 1 Von Willebrand Disease Patient With Recurrent Bleedings In Italy.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study.
Journal: Thrombosis and haemostasis
Published: May 05, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026